Mesa Laboratories (MLAB) Expected to Announce Quarterly Earnings on Tuesday

Mesa Laboratories (NASDAQ:MLAB) is expected to release its Q3 2026 results before the market opens on Tuesday, February 3rd. Analysts expect Mesa Laboratories to post earnings of $2.41 per share and revenue of $63.2330 million for the quarter. Parties may visit the the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 8:00 AM ET.

Mesa Laboratories Price Performance

Shares of Mesa Laboratories stock opened at $78.76 on Friday. The company’s fifty day simple moving average is $81.23 and its two-hundred day simple moving average is $74.36. Mesa Laboratories has a 12-month low of $55.45 and a 12-month high of $155.12. The firm has a market cap of $434.76 million, a PE ratio of -246.13 and a beta of 0.89. The company has a quick ratio of 1.44, a current ratio of 2.02 and a debt-to-equity ratio of 0.95.

Mesa Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Saturday, February 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.8%. Mesa Laboratories’s dividend payout ratio (DPR) is presently -200.00%.

Institutional Investors Weigh In On Mesa Laboratories

Several hedge funds have recently made changes to their positions in the company. Boston Partners grew its stake in Mesa Laboratories by 2,009.5% in the third quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock worth $7,664,000 after purchasing an additional 108,936 shares during the period. Millennium Management LLC boosted its holdings in shares of Mesa Laboratories by 131.9% during the 3rd quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock valued at $8,967,000 after buying an additional 76,107 shares in the last quarter. Kennedy Capital Management LLC boosted its holdings in shares of Mesa Laboratories by 34.3% during the 3rd quarter. Kennedy Capital Management LLC now owns 121,546 shares of the medical instruments supplier’s stock valued at $8,145,000 after buying an additional 31,067 shares in the last quarter. Select Equity Group L.P. grew its position in shares of Mesa Laboratories by 38.3% in the 2nd quarter. Select Equity Group L.P. now owns 102,198 shares of the medical instruments supplier’s stock worth $9,629,000 after buying an additional 28,301 shares during the period. Finally, Gabelli Funds LLC bought a new position in shares of Mesa Laboratories in the 2nd quarter worth about $2,370,000. 90.60% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Mesa Laboratories in a research report on Thursday, January 22nd. Wall Street Zen raised Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Zacks Research upgraded Mesa Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, January 9th. Finally, Wells Fargo & Company lifted their price target on shares of Mesa Laboratories from $75.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $83.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.